BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Clonidine

An imidazoline sympatholytic agent that stimulates ALPHA-2 ADRENERGIC RECEPTORS and central IMIDAZOLINE RECEPTORS. It is commonly used in the management of HYPERTENSION.

299+ PubMed studies analyzed · 45 RCTs · Evidence Score: 49.3

Research Domains

Clonidine has been studied across 18 research domains including ❤️ Cardiovascular, 💊 Pain, 🧠 Focus & Attention, 😴 Sleep, 🌤️ Mood & Depression. The primary research focus is ❤️ Cardiovascular with 27% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Clonidine, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Dexmedetomidine
14 shared targets
Oxymetazoline
15 shared targets
Phentolamine
17 shared targets
Guanfacine
13 shared targets
Guanabenz
16 shared targets
Dihydroergotamine
17 shared targets
Pergolide
14 shared targets
Trazodone
13 shared targets
Quetiapine
16 shared targets
Yohimbine
14 shared targets
Loading evidence profile...

This evidence profile for Clonidine is generated deterministically from 299 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.